Episode #227 of the PricePlow Podcast takes us back to the NNB Nutrition booth at IFT First 2026 in Chicago, where Shawn Wells sat down with Mike and Ben for the first of two conversations recorded on-site. This one skips the usual business updates (that’s what part two, with Dustin Elliott and Jake Mulder, covers) and goes straight for the theoretical side of things: where Wells thinks the next several years of supplement innovation are headed, and the problems NNB’s science team wants solved before anyone else notices they exist.
Shawn Wells’ Working Theories, and Where NNB Nutrition Takes Them
Wells has built a working framework around what he calls “GLP-1 Drag”, three linked theories covering muscle loss, mitochondrial fatigue, and dopamine flattening in people using GLP-1 medications. From there, the conversation covers precision fermentation’s takeover of the herbal extract market, a buccal pouch platform built around fast-absorbing nootropics and stimulants, and an unplanned detour into flush niacin and nicotine pouches.
Subscribe to the PricePlow Podcast on your favorite platform and sign up for NNB Nutrition news alerts before diving in.
Podden och tillhörande omslagsbild på den här sidan tillhör
Supplement Industry Thought Leaders. Innehållet i podden är skapat av Supplement Industry Thought Leaders och inte av,
eller tillsammans med, Poddtoppen.